Clinical Trial: A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281937) titled 'A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities' on Dec. 04.

Brief Summary: The aim of this study is to evaluate the efficacy of VRB-101 for body weight reduction compared to placebo in participants who have obesity or overweight with weight-related comorbidities.

Study Start Date: Nov. 25

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: VRB-101

VRB-101 tablets will be administered orally.

DRUG: Placebo

Placebo tablets will be administered orally.

Recruitment Status: RECRUITING

Sponsor: Verdiva Bio Dev Limited

Discla...